Search results
Can At-Home Vision Tests Detect Active Neovascular AMD?
MedPage Today· 6 days agoThe paper-based KeepSight Journal from the International Macular and Retinal Foundation, Genentech's...
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Zacks via Yahoo Finance· 20 hours agoApellis (APLS) reports first-quarter 2024 results, wherein earnings match the Zacks Consensus...
Scientists find potential treatment target for leading cause of blindness
Investing.com· 6 days agoNew Delhi, May 2 (IANS) US scientists have found answers to why treatment for neovascular...
EyePoint Pharmaceuticals’ stock plunges as eye treatment fails to meet trial goal
Market Watch· 2 days agodropped nearly 30% in premarket trading Monday after the company said its experimental...
Research to Prevent Blindness Opens Applications for Vision Research Grants
Newswise· 3 days ago(RPB) is pleased to announce that it has opened a new round of grant funding for high-impact vision research. With a focus on scientific excellence, RPB funds research across all sight-threatening ...
Telomir Pharmaceuticals sees breakthrough potential in Anti-Aging Treatment with Telomir 1
Proactive Investors· 21 hours agoDrawing from his background in ophthalmology at Johns Hopkins, O'Donnell explained that the drug is...
Stealth BioTherapeutics Announces Participation at Upcoming Ophthalmology Conferences
KTLA-TV Los Angeles· 7 days agoAt the OIS Retina Innovation Summit...
Vision-Language Models for Feature Detection of Macular Diseases on Optical Coherence Tomography
Journal of the American Medical Association· 6 days agoThis cross-sectional study evaluates the performance of a vision-language model in performing ophthalmologic tasks related to interpretation of optical coherence tomography scans.
A Revolution In Gene Therapy Is Unfolding, Bringing Hope for Vision Loss
Newswise· 5 days agoTwo treatments for retinal diseases, invented by Neena Haider, PhD, that currently are in clinical trials run by Ocugen, represent a conceptually broad, new approach that ...
RevOpsis Welcomes Dr. Emmett Cunningham to Strategic Advisory Board
WFRV 5 Green Bay· 5 days agoRevOpsis Therapeutics, a next-generation biopharmaceutical company spearheading innovation in ophthalmic therapies, announced today the appointment of Dr. Emmett Cunningham to its Strategic ...